This Solicitation opportunity from Department Of Defense was posted on July 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Pantoprazole DR
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract solicitation SPE2D2-26-R-0010, issued by the Defense Logistics Agency Troop Support under the Department of Defense, seeks a firm-fixed-price requirements contract for the supply of Pantoprazole DR tablets in specified quantities and packaging formats to support the Prime Vendor Program for DoD, VA, BoP, and IHS customers. The solicitation covers two product configurations—40 mg and 20 mg tablets in 90-count and 1000-count bottles—with estimated base year quantities of 36,219, 51,043, and 108,488 bottles respectively, and identical option year quantities for up to four additional years, for a potential five-year contract term. All pricing must be submitted per bottle and is exclusive of Federal Excise Tax; quantities are estimates and not firm commitments. Offerors must meet stringent pharmaceutical compliance standards, including FDA cGMP certification for all manufacturing facilities, full adherence to the Drug Supply Chain Security Act for traceability and licensing, and compliance with Health Industry Business Communication Council (HIBCC) or GS1-128 standards for unit-of-use barcoding that includes the National Drug Code, lot number, and expiration date. Packaging must support compatibility with automated dispensing systems such as OptiFill and Baxter ATC Canisters, and labeling must avoid placing barcodes solely on outer packaging or across blister pack perforations, with specific orientation guidelines for bottles and vials to ensure machine readability. Proposal submission is strictly electronic via DIBBS, with no acceptance of mail, fax, or email, and requires comprehensive documentation including completed SF 1449 forms, country of origin charts for final products and active pharmaceutical ingredients, a subcontracting plan for large businesses, and certified pricing for base and option years. Offerors must be registered in SAM, with representations and certifications incorporated by reference, and must meet specific trade agreements, Buy American, and foreign ownership disclosure requirements. The evaluation is a pass/fail process based solely on technical acceptability and past performance, with award going to the technically acceptable offeror submitting the lowest price. Contract administration includes a 0.5 percent cost recovery fee payable electronically to the U.S. Treasury with code SP2400, quarterly sales reporting within 60 days of quarter-end, and audit rights reserved for the government. Payments flow from Prime Vendor contractors, not the government, and contractors must execute business-to-business agreements with all DLA
General Info
Place of Performance
PASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
Amendment 0001 included to revise missing information from the solicitation and to inform offerorers that requirements are for DoW use only.
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
